LogiPharma USA 2025: What Were the Standout Trends?

At the 20th anniversary of LogiPharma USA, Dave Malenfant reflected on the event’s growth and its pivotal role in shaping discussions across the pharmaceutical supply chain. With over 700 attendees and standing-room-only master classes, Malenfant emphasized the strong industry engagement and the event’s ability to attract professionals from diverse company sizes and both clinical and commercial supply chain functions.

Looking back over two decades, Malenfant pointed out how the industry and the conference itself have evolved. In the early years, the sector was heavily male dominated, but today, greater female representation is evident across attendees and leadership roles. He credited Logipharma for broadening its reach and relevance, adapting to trends, and becoming, in his view, the premier global conference for pharmaceutical supply chain leaders.

For Malenfant, the continued growth of Logipharma is a testament to its ability to remain timely and relevant, bringing together a community that is both tackling current challenges and preparing for future transformations in supply chain management.

A transcript of Malenfant’s conversation with Pharmaceutical Commerce (PC) can be found below.

PC: What have been some of the trends that have stood out at this year’s conference?

Malenfant: AI, artificial intelligence, and how that plays into the whole area of supply chain, the integrated supply chain, the problem with AI. And we have a lot of discussions on AI. We're going to talk, I've got a moderating a panel that's going to talk about digital transformation and AI and but we have to be careful when you have an agenda that's really in a trend like AI, that we don't forget about the people and try and understand that it takes a new organization, A different kind of skill set in order to manage the trend of AI and other technologies that are coming forth. But AI is by far the number one trend that's going to dominate this year, obviously, and it's going to dominate 2026 and I think it's going to dominate through to 2030.